Literature DB >> 6286338

Mianserin reduces plasma levels of beta-endorphin immunoreactivity in depressed patients.

F Drago, V M Wiegant, G Sapienza, E Aguglia, V Rapisarda, U Scapagnini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6286338     DOI： 10.1007/bf01964095

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  8 in total

1.  International reliability and communicability of a rating scale for depression.

Authors:  M Asberg; P Kragh-Sorensen; R H Mindham; J R Tuck
Journal:  Psychol Med       Date:  1973-11       Impact factor: 7.723

2.  Clinical and EEG effects of GB-94, a "tetracyclic" antidepressant (EEG model in discovery of a new psychotropic drug).

Authors:  T M Itil; N Polvan; W Hsu
Journal:  Curr Ther Res Clin Exp       Date:  1972-07

3.  Increased CSF levels of endorphines in chronic psychosis.

Authors:  L Terenius; A Wahlström; L Lindström; E Widerlöv
Journal:  Neurosci Lett       Date:  1976-10       Impact factor: 3.046

Review 4.  Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

5.  Cerebrospinal fluid endorphins in schizophrenia.

Authors:  R Rimón; L Terenius; R Kampman
Journal:  Acta Psychiatr Scand       Date:  1980-05       Impact factor: 6.392

6.  Vasopressin in cerebrospinal fluid and plasma of man, dog, and rat.

Authors:  J Dogterom; T B van Wimersma Greidanus; D De Wied
Journal:  Am J Physiol       Date:  1978-05

7.  Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway.

Authors:  I Lemaire; R Tseng; S Lemaire
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

8.  Naloxone (Narcan) treatment in depression: clinical observations and effects on CSF endorphins and monoamine metabolites.

Authors:  L Terenius; A Wahlström; H Agren
Journal:  Psychopharmacology (Berl)       Date:  1977-08-31       Impact factor: 4.530
  8 in total
  2 in total

1.  Dissociation between CSF and plasma B-endorphin in major depressive disorders: evidence for a different regulation.

Authors:  F Facchinetti; F Petraglia; G Sances; C Garuti; P Tosca; G Nappi; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

Review 2.  Psychoneuroendocrine research in depression. I. Hormone levels of different neuroendocrine axes and the dexamethasone suppression test.

Authors:  R Rupprecht; K P Lesch
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.